InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Kramer Robert, Chief Executive Officer. Director active across 1 company, notably Emergent BioSolutions Inc.. In total, 9 filings have been recorded. Activity tracked since 8 May 2021. The latest transaction was disclosed on 9 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Robert Kramer is the President and CEO of Emergent BioSolutions Inc. He is responsible for the strategic direction and overall management of the company.